Q7NBF8 AF NFT

Cytadherence high molecular weight protein 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihk3ksdywy7ckd7pkvwzzkybhjpj2bobebbwybsttr3b7xmdyxtby/metadata.json
IPFS of structure file: 
bafybeiemmmqepclmr4y7npuzt4afyp3diflprmcw2pcjig64q35d5wl53q/AF-Q7NBF8-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x40eeFb683B906BDd6284897B2F4EE98a0eAf22bd
First NFT owner address (bech32): 
genesis1grh0k6pmjp4a6c5y39aj7nhf3g827g4awp0s0n
Current NFT ID #175187 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
175187
Accession (UniProt):
Q7NBF8
Name::
Cytadherence high molecular weight protein 2
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2))

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q7NBF8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q7NBF8|HMW2_MYCGA Cytadherence high molecular weight protein 2 OS=Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2)) OX=710127 GN=hlp2 PE=3 SV=1 MQKDYMKLHSNSDFDADQLDEHDDNVFQDVYDTGFDDGYIKANQENLIANQYKKLDKNSYQNGNNSFYTKDELEKLKKQSFQVNQDIDYYQQAQTEISSERQRLLQAIDDLEANQDQFHPEDFQAERQYLINELDRLDSELYHIEQYKNDSIDFVNELNQRLSAEQAKIDSYNSSLDKNIRKDYIQIDQLKNKLAEETTEYNDLLNRSTDEISEIDRQSERLQNLIDERIAKLNNDSYGVSSLDSSTRERLKKEIHDLSEQRKKLQSAKKLHLYNLNLKKESIRRYRSQLEQYLESLKQMRNEHNKKLKGYAQNLDNIKNEVEKAKQNFNDQQLKILQSKANADQYFALRKIELENSYKKAKNAILEANKAHAKNVQEEQALANKNNKTQRLLNKLKEDYDRLKIASLSFESMRKQSLAALNNLQDELKQKHNLLERKKHEQDGIVNEKISELEGYRSDLVDQKLKIEREKENQERRYKAAEASLNKKRQEIDELFLEANTKLNEASLKENDLNNQKREILAKLRNLEHLKSEIDQRRRDLDQRELIDQQTIRKIQLDVESERADLQRILLIERKKNDERQQELLQYERDIKRQQTDFENTVNWEQKKLSQREKELKDGYEQLQLKQSEVQEKIDELNEEINRAQKSKQNSLVLEQKLKSDLEHLNLSKNYLDKQQEELNQKSDKMIEDLKVFERDLKRQKEDLSIYEKSLQQKEASLINFQNDVTVQKNEAYHKAQAIHQELELKKAAIENELRKLTAERKAVDADKEENTKLKKFIDEEIRSLANERKELEIYQNNIENFKNNAVDRLNVLESDLVKKRNELEQLKKEQQTHYNELNSNLTNELQELEEQKKKFAHQKQQKFEELLQAKNNLSIKENELVLYAQKVNDRYNELKAIEKSNTAKSEMINAKLEEFKHAEIDYLNYQNKIKQEQIKFDNQVKILESQYNQRNEILLIREEQIKQKKAEQQAQEKQIQKDFKRLQEEKNNFDDQKRNKFNKISNLYLEIKKQRDEVDLAQRQIEDQKEELLIKAREGRLQKQEIEDRLAVLEKSEKRFRQEDELLAKKRIDLIERIGVLKADINKKHEILSLRSVQLTEKAKKQQEKDADLQRKFDLLESEVERFNEEKKSEFQKLKVERDKLAHREKNVSKNMNEINLALAKLDLIRKNNKVDKAKINEKLALLNDQKEKIDRENDLLDAKKTEVITRLRKMENDLEFEKQKVLLDRSNIERISSDQQALARELETKYQTLEREKRSFSQRKENELKEIDDFYQQVQHKERTLNLKIEDLKQLRYLLEKESYNVNVNKKDLKVRIEHYQRLERAIKNEQHKLNNQKNNFFNKVELLNDQLNKKSSKIALLRSKIYNTYKQQQQQKQILLEEKHKNSQLRKSLLKTQEELHQQKAQFSIAKKQEEKKLKNQKDLIQNTLSEVIKQKDQITNIKQEVDLKQTQLNNLEKLIIKQRADLQKELEKNSENTYRLQKAERLLEEKKTKLRLEYDKAKKVLSTAKATDQALKTKQAKVQDQFKKLVLINKKIIEARNNLLKQRNIIQKEINNRNMANFQNPYPNFLNLAPNTQVVPAQTIMPVQTPQLVGVNYPNQPAFDFNNPLMQMQQLINQQQMLMMQKEHQWALEEANKKNSRLAKQLKQLKHHKQALTESTSEHLNYHNLLNADNSYKINSLQNLLSKVAYNTKRRINQLEHNLDPETADLNQLHELNANSQLLDEIRTVLSNTTTNTNAVVPANSYSKELRMLFDEIKADFKKQAVLFNTQKEVFTNQINQLAQAVEQGPIEVRKTLESQDQKYQQMFDNFRDAYEQNISLLRNENNEVQKKLTDLYDEIAAIKTNTEKIKKTTLRPEVRNNANEGLASFNSVNRDKKDYLDQTLPVHQNLRIDLNQNRDLSHAKKERINQLANEIKTIKELIEKRKQTSL